Creation of Shareholder Value in the Pfizer-AstraZeneca Deal - Paperback-Fast Shipping
Sale!

Creation of Shareholder Value in the Pfizer-AstraZeneca Deal – Paperback-Fast Shipping

Original price was: $49.28.Current price is: $14.78.

SKU: 7950051278983 Category:

Description

by
Markus Bäder (Author)

Essay from the year 2015 in the subject Business economics – Investment and Finance, grade: 1. From a shareholder perspective this should, however, cause serious concern as the deals very rarely maximise the owner’s wealth. This essay is going to critically evaluate the concepts of shareholder wealth creation, in light of appropriate evaluation methods for bids and the influence of capital structure. It will be concluded that information asymmetry was one of the core issues in the case, as both parties ultimately misestimated potential synergies. Moreover, it is argued that irrational decisions, made by executive, can significantly impact and eventually destroy shareholder value.

Number of Pages: 24Dimensions: 0.06 x 8.27 x 5.83 INPublication Date: July 19, 2016

Reviews

There are no reviews yet.

Be the first to review “Creation of Shareholder Value in the Pfizer-AstraZeneca Deal – Paperback-Fast Shipping”

Your email address will not be published. Required fields are marked *